Hybridoma · 1983 · 30 citations · 28 references
Life SciencesGeneticsImmunologyCancer ImmunologyCellular ImmunologyImmunogeneticsAlloantigen RecognitionLymphoid TissueMajor Histocompatibility ComplexT Cell BiologyT Cell Responses To TumorsTumor AntigensHybridoma Cell Line DevelopmentHybridoma Cell LinesHybridoma-derived AntibodiesInbred Strain GeneticsLymphocyte PhenotypingLymphocyte SubtypesMyeloma Cell LinesRecombinant Inbred Lines
Spleen cells from a DBA/2 mouse immunized with RL male 1 tumor cells, a radiation induced BALB/c T-cell leukemia, were hybridized with the nonsecretor myeloma line NS.1. Four established hybrid cell lines continuously secreted antibodies that recognized a new alloantigenic specificity, tentatively called Ly-m22. This antigen is detectable on nearly 60% of lymph node cells, and 30% of spleen cells by direct cytotoxicity assay, but did not lyse significant number of cells of thymus and bone marrow. By absorption test, these lymphoid organs, i.e., lymph node, spleen, thymus, and bone marrow, were shown to express Ly-m22 determinant. The newly found antigen is expressed predominantly on T-cells. Analysis of BXD and SWXL recombinant inbred strains revealed close linkage between Ly-m22 and Ltw-4 loci on chromosome 1. The estimated recombination frequency is 0.027 +/- 0.081.
28
Continuous cultures of fused cells secreting antibody of predefined specificity
Georges Köhler, César Milstein · Nature · 1975 · 17.2K citations
Pharmacy, Cell Biology, Immunology +11
Ly-m11: TheH-3 region of mouse chromosome 2 controls a new surface alloantigen
Nobuhiko Tada, Shoji Kimura, Antoinette Hatzfeld et al. · Immunogenetics · 1980 · 112 citations
Isolation and characterisation of a bipotential haematopoietic cell line
T. M. Dexter, Terence Allen, David J. Scott et al. · Nature · 1979 · 104 citations